Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:49 p.m.

    📋 IRONWOOD PHARMACEUTICALS, INC. (IRWD) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:06:58

    Event Type: Financial Results

    Event Details:

    Ironwood Pharmaceuticals Inc (IRWD) Reports Q3 2022 Financial Results Ironwood Pharmaceuticals Inc (IRWD) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 163774
    • Net Income: 37080
    • EPS: $37,080
    • Cash and equivalents: 504365
      • 1 million shares of Class A Common Stock at an average price per share of $
      • ·In June 2022, Ironwood repaid the remaining $
      • 7 million aggregate principal amount of the 2022 Convertible Notes in full. 3 Pipeline Updates Pediatric Program ·Ironwood and AbbVie are currently advancing the linaclotide clinical pediatric program to potentially expand the clinical profile of LINZESS (assuming positive data and FDA approval). –The functional constipation study in 6
        • targeting the liver. If successful, CNP-104 has the potential to be the first approved PBC disease modifying therapy. –COUR is currently conducting a clinical study for CNP-104 evaluating the safety, tolerability, pharmacodynamic effects and efficacy of CNP-104 in PBC patients, and remains on track with a data readout estimated in 2023

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Assets Prepaid Expenses Other Current Assets 9.85K 8.69K $1.17K +13.41%
    Assets Property Equipment Net 6.96K 7.58K $-611.00 -8.07%
    Assets Operating Lease Right Of Use Assets 14.70K 15.35K $-650.00 -4.23%
    Assets Other Assets 872.00 1.00K $-128.00 -12.80%
    Liabilities And Stockholders Equity Accounts Payable 317.00 935.00 $-618.00 -66.10%
    Operating Expenses Selling General Administrative 27.05K 58.98K $-31.93K -54.14%
    Other Expense Income Interest Expense 7.73K 4.55K $3.18K +70.01%
    Adjustments Interest Expense 7.73K 4.55K $3.18K +70.01%
    Revenue 104.03K 104.03K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 8.69K 8.69K $0.00 +0.00%
    Property and Equipment, Net 7.58K 7.58K $0.00 +0.00%
    Other Assets 1.00K 1.00K $0.00 +0.00%
    Accounts Payable 935.00 935.00 $0.00 +0.00%
    Operating Lease Liabilities 3.13K 3.13K $0.00 +0.00%
    Selling, General & Administrative 27.05K 58.98K $-31.93K -54.14%
    Interest Expense 7.73K 4.55K $3.18K +70.01%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Ironwood Pharmaceuticals Inc
    • CIK: 0001446847
    • Ticker Symbol: IRWD
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories